Your Source for Venture Capital and Private Equity Financings

Venture Capital News: Koneksa Raises $45M Series C

2022-02-07
NEW YORK, NY, Koneksa, a leader in designing and validating digital biomarkers, announced the completion of a $45M Series C, led by AyurMaya.
Koneksa, a leader in designing and validating digital biomarkers to accelerate drug development, announced the completion of a $45M Series C financing round, led by AyurMaya, an affiliated fund of Matrix Capital Management, with participation from Takeda Ventures and Velosity Capital.

Existing investors McKesson Ventures, Merck Global Health Innovation Fund, Novartis (dRx Capital), Spring Mountain Capital and Waterline Ventures also joined the financing round. Koneksa has raised approximately $65M in gross proceeds from private financings to date.
(c) by Massinvestor, Inc. For contact info, please check out our about page.
>> Click here for in-depth research on 9,000+ startups and 5,000+ VC investors